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mDITORIAL COMMENT
ascular Structure Versus
unction: Is Endothelial
ysfunction of Independent
rognostic Importance or Not?*
. B. John Mancini, MD, FRCPC, FACC
ancouver, Canada
n this issue of the Journal, Fathi et al. (1) describe the value
f measuring vasomotor endothelial dysfunction and intima
edial thickness of the far wall of the common carotid
rtery as predictors of clinical outcome in patients at risk for
ardiovascular events. This adds to a growing-but-small list
f publications exploring this important theme, but in
ontrast to most of the previous literature, the authors
uggest that endothelial dysfunction does not add indepen-
ent prognostic information when considered in the context
f other test results.
See page 616
Previous investigations are summarized in Table 1, which
s organized according to the method used to measure
ndothelial dysfunction. The investigations undertaken at
he time of coronary angiography and those using venous
cclusion plethysmography in conjunction with intra-
rachial injection of test agents represent important, “proof
f concept” studies (2–8). Those using brachial artery cuff
cclusion and ultrasound to measure flow-mediated dilation
9–14) investigate an approach with a potentially broad
linical applicability and use the methodology most compa-
able with the study from the University of Queensland (1).
ll of these works, including the current one, conclude that
easures of endothelial vascular dysfunction are of prog-
ostic importance. The main issue is whether this informa-
ion is additive to currently available testing methods,
articularly imaging tests.
Of the studies performed at the time of cardiac catheter-
zation, the study by Hollenberg et al. (4) pertains only to a
mall cohort of patients undergoing orthotopic cardiac
ransplantation, and the measures of coronary endothelial
ysfunction were not evaluated in any multivariate analysis
odel. The study by Suwaidi et al. (2) was undertaken in a
ore common cohort of patients with angiographic coro-
ary disease. The prognostic importance of severe coronary
ndothelial dysfunction was robust enough to emerge from
logistic regression analysis as an independent predictor,
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Cardiovascular Imaging Research Core Laboratory, Vancouver Hospital,iniversity of British Columbia, Vancouver, Canada.ven though the results were not reported explicitly. Some
f the alternative imaging methods evaluated by these
nvestigators included stress tests, measures of ejection
raction, results of coronary intravascular ultrasound, and
he number of main coronary artery vessels with significant
tenosis. Schachinger et al. (3) indicate that the prognostic
alue of coronary endothelial dysfunction was upheld even
n consideration of the degree of underlying, angiographic
oronary disease. Similar findings were noted by Halcox et
l. (5), who also included measures of ejection fraction in
heir multivariate analyses.
Perticone et al. (7) and Heitzer et al. (8) used the method
f forearm venous plethysmography. Although both groups
oncluded that measures of endothelial dysfunction were of
rognostic importance, only Heitzer et al. (8) indicated that
his was independent of the number of significantly diseased
essels based on angiography.
There are significant limitations in similar studies that
sed completely non-invasive methods (9–13). For exam-
le, Gokce et al. (10,11) and Brevetti et al. (12) studied only
atients with peripheral vascular disease. Modena et al. (13)
tudied only post-menopausal, hypertensive females with
ndothelial dysfunction at baseline. None incorporated
ther imaging-based, risk stratification methods. The study
y Neunteufl et al. (9), based on only 73 patients, actually
ound no independent prognostic importance of flow-
ediated dilation measurement when angiographic coro-
ary vessel disease (30% diameter stenosis) was incorpo-
ated into a multivariate analysis. Chan et al. (14) evaluated
he prognostic importance of flow-mediated dilation in the
ontext of extensive metabolic tests, exercise stress tests,
arotid ultrasound measures of carotid plaque, and intima
edial thickness. The non-invasive measurement of endo-
helial dysfunction was the dominant, independent predic-
or of outcome in a cohort of coronary patients enrolled in
n intensive, cardiac rehabilitation program. Carotid ultra-
ound measures of atheroma burden also were predictive.
ven more important, endothelial dysfunction appeared to
odulate the prognostic impact of the degree of carotid
theroma burden. That is, the worst prognosis was seen in
hose patients with severe grades of endothelial dysfunction
oncomitant with a high degree of carotid plaque. Accord-
ngly, both vascular structure and function appeared to be
mportant. However, the study consisted of only 152 pa-
ients.
The current study (1) adds in many important ways to this
elatively small body of literature. Excluding a predominantly
etrospective analysis (6), the current work represents the
argest cohort of patients (444 subjects) of any of the studies. It
sed non-invasive measures of endothelial dysfunction; there-
ore, the results are potentially applicable in a broad way. The
ollow-up time period and event rates were substantial enough
o allow assessment of predictive power with respect to total
ortality, cardiovascular death, and cardiovascular events. Itncorporated the Framingham models, thereby providing a way
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February 18, 2004:624–8 Editorial Commento link the results to a common method used to stratify global
isk. Most importantly, the authors incorporated sophisticated,
ultivariate analyses to tease out independent predictors of risk
rom an extensive battery of commonly available tests, in
ddition to endothelial dysfunction measurement. In this
egard, the work is similar in methodology to that of Chan et
l. (14), and they represent the only studies that incorporate
arotid ultrasound measurements.
Despite these strengths, the conclusion that endothelial
ysfunction measurement is not independently predictive of
utcome is at variance with many of the preceding works. It
s also at variance with general experience in other cardio-
ascular arenas. For example, for any given ejection fraction,
atients with a higher functional capacity have a better
rognosis. For any given degree of coronary disease, those
ith inducible ischemia fare worse. Is the current literature,
hich is dominated by articles suggesting that endothelial
ysfunction is an independent predictor of prognosis,
erely a reflection of publication bias, or are there reasons
o mollify the negative conclusions? The patient cohort is
efinitely different from those of previous studies. Based on
able 1 of the article (1), fully 75% of the cohort had renal
ysfunction, of which a substantial proportion were on
ialysis and/or transplanted. The risk profile and the battery
f tests that might be useful in this cohort may be substan-
ially different than in a more typical population. This large
ubgroup is very likely to have had an advanced degree of
therosclerotic burden and left ventricular hypertrophy that
ould not be expected in a more general population. Even
he subgroup of “multiple risk factor patients” included 132
atients (over 80% of the subgroup) with either chronic
enal impairment or previous kidney transplantation. Al-
ost 30% of the entire cohort and 21% of the “multiple risk
actor” subgroup were diabetics, representing yet another
roup with a high likelihood of more advanced structural
isease of the vasculature. Furthermore, 14% of the cohort
ad very advanced coronary disease not amenable to revas-
ularization. These concerns about the nature of the patient
opulation are strengthened by the finding that the actual
vent rates in the cohort overall and in all the subgroups
ere greater than predicted by the Framingham algorithms.
ndeed, in the dialysis patients without previous myocardial
nfarction and in the “multiple cardiovascular risk factor”
roup, the actual event rates were higher than predicted by
actors of 5.6 and 2.2, respectively. Accordingly, measures of
ascular endothelial function, often present long before
tructural disease, may not be useful in cohorts already at
ery elevated risk and in whom structural abnormalities such
s intima medial thickness and left ventricular hypertrophy
re already well entrenched.
A second reason for mollifying the conclusions of the
tudy pertains to the absence of functional testing, other
han flow-mediated dilation testing, in a large component of
he cohort. Nearly 40% of the cohort did not undergo stress
esting. In the subanalysis that was based on 277 patients
ho did undergo stress testing, it is fascinating to note that dhe resulting, independent, image-based predictors of events
ere the measurements of endothelial dysfunction, intima
edial thickness, and left ventricular hypertrophy. These
esults were not emphasized by the authors, but they are
emarkably concordant with those of Chan et al. (14).
The work also shares several limitations with most of the
revious studies in this field. It is well known that endo-
helial dysfunction can be treated with several classes of
gents, notably angiotensin-converting enzyme inhibitors
nd statins among many other classes. The authors have no
nformation on how the prognostic importance of initial
nd/or serial measures of endothelial function might have
een altered by changes in treatment occurring during the
ong follow-up period. Modena et al. (13) demonstrated
hat a beneficial response to antihypertensive therapy and
hat a subsequent, low event rate could be predicted based
n whether endothelial dysfunction improved or not within
he first six months of treatment. Similarly, Chan et al. (14)
emonstrated that outcome was predicted not solely by the
egree of baseline endothelial dysfunction measurement but
lso by whether intensive, secondary prevention treatment
esulted in an improvement or not of endothelial dysfunc-
ion. In contrast, carotid ultrasound changes were not
redictive within this timeframe. If these findings were
ubstantiated, it would suggest that treatment intensifica-
ion or modification could be guided by measuring endo-
helial function serially. This gauge of therapy could be
btained long before any expected changes in structure, such
s left ventricular hypertrophy or carotid atheroma.
There is evidence to suggest an interdependence of the
ascular inflammatory process, as reflected by high sensitiv-
ty C-reactive protein, and the presence of vasomotor
ndothelial dysfunction. Although both may also correlate
ith overall Framingham risk calculations, neither is highly
orrelated to individual risk factors or when Framingham
isk is low (15,16). Thus, a second limitation shared with all
ther research in this field is a lack of analysis of the
redictive role of endothelial dysfunction measurements
hen high sensitivity C-reactive protein measurements are
lso available in the same patients.
The investigators should be congratulated for putting
ndothelial dysfunction assessment into a context that
ncludes many of the standard testing methodologies. But
he conclusions should not be extrapolated without due
egard to the cohort upon which the conclusions are based.
he ultimate value of this work is to encourage further
tudies of a similarly rigorous and clinically relevant nature
o determine when novel risk assessment methods might be
f greatest use. In the area of endothelial dysfunction
easurement, there is a striking need to determine the
rognostic value of the approach in a cohort of patients for
hom cardiovascular risk prediction is more tenuous than in
ost of the populations studied to date. Virtually none of
he articles reviewed at this time pertain solely to popula-
ions without manifest cardiovascular disease or without
iseases that have a high a priori likelihood of underlying
Table 1. Investigations of the Prognostic Importance of Vasodilatory Endothelial Dysfunction Measurements
Institution (Reference) Number and Type of Patients
Duration of
Follow-Up Events Main Conclusions
Invasive measurements performed at the time of coronary angiography
Mayo Clinic (2) 157 patients with mild angiographic
CAD
28 months
(mean)
Cardiovascular death
Myocardial infarction
Coronary revascularization
Events limited to patients with severe endothelial dysfunction.
Logistic regression analysis described in methods but results
not reported. Potential alternative imaging methods
available were stress tests, ejection fraction, intravascular
ultrasound, and number of angiographic vessel disease.
Goethe University (3) 147 patients undergoing angiography for
evaluation of chest pain or single-
vessel percutaneous intervention
7.7 yrs
(median)
Cardiovascular death
Myocardial infarction
Coronary revascularization
Peripheral revascularization
Unstable angina
Stroke
Endothelial dysfunction shown to be of independent
prognostic importance even when number of coronary
vessel disease (30% diameter stenosis) was included in
multivariate model.
Rush-Presbyterian-St. Luke’s
Medical Center (4)
73 orthotopic heart transplant recipients
undergoing angiography with no
rejection and no angiographic disease
50% diameter stenosis at baseline
32 months
(mean)
Cardiac death
Cardiac allograft vasculopathy
Endothelial dysfunction predictive of events, but no
multivariate analyses were performed.
National Institutes of Health
(5)
308 patients with or without
angiographic coronary disease
46 months
(mean)
Cardiovascular death
Myocardial infarction
Unstable angina
Stroke
Endothelial dysfunction independently predictive of events in
models including presence of angiographic coronary disease
(extent not quantified) and ejection fraction.
Mayo Clinic (6) 503 patients without angiographic
coronary disease 30% diameter
stenosis
Up to 90
months
Cerebrovascular events Endothelial dysfunction independently predictive of events
but models included no other imaging methods.
Conclusions based mainly on retrospective data.
Invasive measurements using forearm venous plethysmography
University of Catanzaro
Magna Graecia (7)
225 newly diagnosed hypertensives 31.5 months
(mean)
Myocardial infarction
Coronary revascularization
Unstable angina
Stroke
Transient ischemic attack
Aortoiliac occlusive disease
Endothelial dysfunction predictive of events in stepwise
modeling but no other imaging methods evaluated.
Hamburg-Eppendorf
University Clinic (8)
281 patients with angiographic coronary
disease
4.5 yrs (mean) Cardiovascular death
Myocardial infarction
Coronary revascularization
Peripheral revascularization
Stroke
Endothelial dysfunction predictive and independent of
angiographic number of vessel disease (but not defined).
Continued on next page
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Table 1. Continued
Institution (Reference) Number and Type of Patient
Duration of
Follow-Up Events Main Conclusions
Non-invasive measurement based on brachial artery flow-mediated dilation
University of Vienna (9) 73 patients requiring angiography 5 years
(mean)
Cardiovascular death
Myocardial infarction
Coronary revascularization
No independent value of endothelial dysfunction
measurement when considered in multivariate model that
included number of diseased coronary vessels 30%
diameter stenosis.
Boston University (10) 187 patients requiring elective vascular
surgery
30 days Cardiovascular death
Myocardial infarction
Unstable angina/ischemic
Ventricular fibrillation
Stroke
Increased troponin
Endothelial dysfunction independently predictive of events
but no other imaging methods were evaluated. Results were
the same when troponin elevations were excluded as events.
Results confirmed during longer observation period in a
follow-up report (11).
University of Federico II
(12)
131 patients with peripheral vascular
disease
23 months
(mean)
Cardiovascular death
Myocardial infarction
Coronary revascularization
Unstable angina
Stroke
Transient ischemic attack
Carotid endarterectomy
Peripheral revascularization/
critical limb ischemia
Endothelial dysfunction and ankle-brachial pressure index
were independent predictors of events.
University of Modena (13) 400 post-menopausal, mildly
hypertensive women with impaired
endothelial dysfunction at baseline
67 months
(mean)
Stroke
Transient ischemic attack
Acute pulmonary edema
Lack of improvement of endothelial dysfunction after 6
months of anti-hypertensive treatment identified a
subgroup with increased event rate. Multivariate analyses
performed but no other imaging modalities evaluated.
University of British
Columbia (14)
152 coronary patients in a rehabilitation
program
34 months
(mean)
Cardiovascular death
Myocardial infarction
Coronary revascularization
Unstable angina
Stroke
Transient ischemic attack
Carotid endarterectomy
At baseline, endothelial dysfunction and measures of carotid
plaque independently predicted events. During follow-up,
deterioration in endothelial dysfunction predicted clinical
events whereas changes in carotid ultrasound measurements
did not.
University of Queensland (1) 444 patients at risk of coronary events 24 months
(median)
All-cause mortality
Cardiovascular death
Myocardial infarction
Stroke
Revascularization
Endothelial dysfunction not predictive of mortality,
cardiovascular death, or cardiovascular events in multivariate
models, including intima medial thickness and left
ventricular mass measurements except in subgroup of
patients in whom stress testing results were available.
CAD  coronary artery disease.
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Editorial Comment February 18, 2004:624–8ascular disease. Novel risk assessment methods that go
eyond the current algorithms, such as the Framingham risk
ssessment algorithm, may well find their niche in uncom-
licated patients at low or moderate risk of events. Even so,
ndothelial dysfunction measurement must be clearly shown
o be applicable in a clinical setting by developing more
ractical and reproducible methodologies and by standard-
zing the reporting of results. These milestones have not
een achieved yet (17). Therefore, although it is true that
ndothelial dysfunction testing is not yet ready for “prime
ime,” it is also true that the quest to determine the
ptimum way to use this approach for assessing prognosis
nd for monitoring treatment should continue undeterred.
eprint requests and correspondence: Dr. G. B. John Mancini,
ancouver Hospital, 3300-950 West 10th Avenue, Vancouver,
ritish Columbia, Canada V5Z 4E3. E-mail: mancini@
nterchange.ubc.ca.
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